Recall alert: More eye products recalled because of contamination

By MDLinx staff
Published February 23, 2023

Key Takeaways

  • Global Pharma agrees to recall Delsam Pharma’s Artificial Eye Ointment because of contamination.

  • This follows the recall of EzriCare Artificial Tears, which was connected to injury and death.

  • Physicians and patients should immediately stop using the eye ointment.

Earlier this month, the Centers for Disease Control and Prevention alerted the public to potentially deadly bacteria in EzriCare Artificial Tears.[] Now, the US Food and Drug Administration (FDA) has announced additional recalls related to eye care.

Yesterday, the FDA asked Global Pharma to recall Delsam Pharma’s Artificial Eye Ointment because of potential bacterial contamination.[] The company agreed to recall the product. Physicians and patients should stop using the over-the-counter product.

It is unclear what kind of bacteria was found in Delsam Pharma’s Artificial Eye Ointment although Global Pharma manufactures both EzriCare Artificial Tears and the newly recalled eye ointment.

EzriCare Artificial Tears recall

EzriCare Artificial Tears was recalled recently after a range of infections, including sepsis, were connected to the drops. Patients reported permanent eye loss and one patient died after using the drops.

Related: Recall alert: Vision loss, death connected to EzriCare Artificial Tears
Share with emailShare to FacebookShare to LinkedInShare to Twitter